Results 51 to 60 of about 2,660,664 (273)

Complement C3a Receptor Antagonist Alleviates Tau Pathology and Ameliorates Cognitive Deficits in P301S Mice.

open access: yesBrain Research Bulletin, 2023
Human tauopathies, including Alzheimer's disease (AD), are a major class of neurodegenerative diseases characterized by intracellular deposition of pathological hyperphosphorylated forms of Tau protein.
Yi Yao   +9 more
semanticscholar   +1 more source

C3a Receptor Inhibition Protects Brain Endothelial Cells Against Oxygen-glucose Deprivation/Reperfusion. [PDF]

open access: yesExp Neurobiol, 2019
The complement cascade is a central component of innate immunity which plays a critical role in brain inflammation. Complement C3a receptor (C3aR) is a key mediator of post-ischemic cerebral injury, and pharmacological antagonism of the C3a receptor is ...
Ahmad S   +6 more
europepmc   +2 more sources

C3aR plays both sides in regulating resistance to bacterial infections.

open access: yesPLoS Pathogens, 2022
Activation of the complement pathway results in the production of bioactive C3a, a product of C3 cleavage, which interacts with membrane-bound receptor C3aR to regulate innate immune cell function and outcome of bacterial infection.
Jesse A Corcoran, Brooke A Napier
doaj   +2 more sources

Complement C3a activates astrocytes to promote medulloblastoma progression through TNF-α

open access: yesJournal of Neuroinflammation, 2022
Background Medulloblastoma (MB) is the most common malignant brain tumor in children. Approximately one-third of MB patients remain incurable. Understanding the molecular mechanism of MB tumorigenesis is, therefore, critical for developing specific and ...
Biao Gong   +9 more
doaj   +1 more source

Potent Thiophene Antagonists of Human Complement C3a Receptor with Anti-Inflammatory Activity

open access: greenJournal of Medicinal Chemistry, 2020
Structure-activity relationships for a series of small-molecule thiophenes resulted in potent and selective antagonism of human Complement C3a receptor. The compounds are about 100-fold more potent than the most reported antagonist SB290157.
Jessica A. Rowley   +11 more
openalex   +3 more sources

Complement C3b contributes to Escherichia coli-induced platelet aggregation in human whole blood

open access: yesFrontiers in Immunology, 2022
IntroductionPlatelets have essential functions as first responders in the immune response to pathogens. Activation and aggregation of platelets in bacterial infections can lead to life-threatening conditions such as arterial thromboembolism or sepsis ...
Anne Landsem   +14 more
doaj   +1 more source

A C3(H20) recycling pathway is a component of the intracellular complement system [PDF]

open access: yes, 2017
An intracellular complement system (ICS) has recently been described in immune and nonimmune human cells. This system can be activated in a convertase-independent manner from intracellular stores of the complement component C3. The source of these stores
Botto   +11 more
core   +2 more sources

C3a/C3aR synergies with TGF-β to promote epithelial-mesenchymal transition of renal tubular epithelial cells via the activation of the NLRP3 inflammasome

open access: yesJournal of Translational Medicine, 2023
Background Complement component 3a and its receptor (C3a/C3aR) and the nucleotide-binding oligomerization domain-like receptor protein-3 (NLRP3) inflammasome contribute to epithelial-mesenchymal transition (EMT).
Danyu You   +7 more
doaj   +1 more source

Complement C3a Enhances the Phagocytic Activity of B Cells Through C3aR in a Fish

open access: yesFrontiers in Immunology, 2022
The complement system is an important part of the immune system of teleost fish. Besides, teleost B cells possess both phagocytic activity and adaptive humoral immune function, unlike mammalian B1 cells with phagocytic activity and B2 cells specific to ...
Zi-You Ma   +19 more
doaj   +1 more source

Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage [PDF]

open access: yes, 2015
Hypoxic-ischemic encephalopathy (HIE) is a clinical condition in the neonate, resulting from oxygen deprivation around the time of birth. HIE affects 1-5/1000 live births worldwide and is associated with the development of neurological deficits ...
Hristova, M, Rocha-Ferreira, E
core   +1 more source

Home - About - Disclaimer - Privacy